BiondVax Pharmaceuticals (NASDAQ:BVXV) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance Shares of BVXV opened at $1.32 on Wednesday. BiondVax Pharmaceuticals has a 12-month low of $1.25 and a 12-month high of $11.80. The firm […]

Related Keywords

Israel , ,Exchange Commission ,News Ratings For Biondvax Pharmaceuticals Daily ,Hedge Funds Weigh In On Biondvax Pharmaceuticals ,Biondvax Pharmaceuticals Ltd ,Biondvax Pharmaceuticals ,University Medical Center ,Nasdaq ,Envestnet Asset Management Inc ,Biondvax Pharmaceuticals Price Performance ,Max Planck Society ,Free Report ,Asset Management ,Get Free Report ,Vax Pharmaceuticals Ltd ,Biondvax Pharmaceuticals Daily ,Nasdaq Bvxv ,Bvxv ,Medical ,Initiated Coverage ,Stocknews Com ,